Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
IEEE Transactions on Medical Imaging|August 10, 2019
Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67Mira Valkonen, Jorma Isola, Onni Ylinen, et al.
Molecular Cancer Therapeutics|January 7, 2005
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancerMinna Tanner, Anita I Kapanen, Teemu Junttila, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2005
Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomasMiikka Korja, Jukka Finne, Toivo T Salmi, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 18, 2010
Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancerKauko Saarilahti, Petri Bono, Mikael Kajanti, et al.
Molecular Cancer Therapeutics|July 12, 2019
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab EmtansineVadim Le Joncour, Ana Martins, Maija Puhka, et al.
Cancer Research|February 8, 2005
Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell linePeter Nagy, Elza Friedländer, Minna Tanner, et al.
Digestive Diseases and Sciences|November 3, 2020
A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal BiopsiesAlina Popp, Juha Taavela, Paolo Graziano, et al.
Human Pathology|May 14, 2005
Web-based virtual microscopy in teaching and standardizing Gleason gradingHenrik Helin, Mikael Lundin, Johan Lundin, et al.
Digestive Diseases and Sciences|November 25, 2020
Correction to: A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal BiopsiesAlina Popp, Juha Taavela, Paolo Graziano, et al.
International Journal of Oncology|December 18, 2001
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neckJan Akervall, Ake Borg, Michael Dictor, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
IEEE Transactions on Medical Imaging|August 10, 2019
Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67Mira Valkonen, Jorma Isola, Onni Ylinen, et al.
Molecular Cancer Therapeutics|January 7, 2005
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancerMinna Tanner, Anita I Kapanen, Teemu Junttila, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 2005
Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomasMiikka Korja, Jukka Finne, Toivo T Salmi, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 18, 2010
Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancerKauko Saarilahti, Petri Bono, Mikael Kajanti, et al.
Molecular Cancer Therapeutics|July 12, 2019
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab EmtansineVadim Le Joncour, Ana Martins, Maija Puhka, et al.
Cancer Research|February 8, 2005
Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell linePeter Nagy, Elza Friedländer, Minna Tanner, et al.
Digestive Diseases and Sciences|November 3, 2020
A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal BiopsiesAlina Popp, Juha Taavela, Paolo Graziano, et al.
Human Pathology|May 14, 2005
Web-based virtual microscopy in teaching and standardizing Gleason gradingHenrik Helin, Mikael Lundin, Johan Lundin, et al.
Digestive Diseases and Sciences|November 25, 2020
Correction to: A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal BiopsiesAlina Popp, Juha Taavela, Paolo Graziano, et al.
International Journal of Oncology|December 18, 2001
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neckJan Akervall, Ake Borg, Michael Dictor, et al.
Pageof 15